Generic automated method for liquid chromatography-multiple reaction monitoring mass spectrometry based monoclonal antibody quantitation for preclinical pharmacokinetic studies.
Zhang, Qian; Spellman, Daniel S; Song, Yaoli; Choi, Bernard; Hatcher, Nathan G; Tomazela, Daniela; Beaumont, Maribel; Tabrizifard, Mohammad; Prabhavalkar, Deepa; Seghezzi, Wolfgang; Harrelson, Jane; Bateman, Kevin P.
; 86(17): 8776-84, 2014 Sep 02.
Artigo em Inglês | MEDLINE | ID: mdl-25010922
Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models.
Effect of high mannose glycan pairing on IgG antibody clearance.
Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies.
Prediction of tissue concentrations of monoclonal antibodies in mice from plasma concentrations.
External Evaluation of Population Pharmacokinetic Models of Infliximab in Patients With Inflammatory Bowel Disease.
Application of PBPK modeling to predict monoclonal antibody disposition in plasma and tissues in mouse models of human colorectal cancer.
Preclinical Pharmacokinetics Evaluation of Anti-heparin-binding EGF-like Growth Factor (HB-EGF) Monoclonal Antibody Using Cynomolgus Monkeys via (89)Zr-immuno-PET Study and the Determination of Drug Concentrations in Serum and Cerebrospinal Fluid.
Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan.
Antibody drug quantitation in coexistence with anti-drug antibodies on nSMOL bioanalysis.
Pharmacokinetic characterization of BMS-936561, an anti-CD70 antibody-drug conjugate, in preclinical animal species and prediction of its pharmacokinetics in humans.